Intellia Therapeutics
NTLA
#5607
Rank
S$1.78 B
Marketcap
S$12.70
Share price
1.65%
Change (1 day)
15.31%
Change (1 year)

EPS for Intellia Therapeutics (NTLA)

EPS in 2026 (TTM): S-$4.33

According to Intellia Therapeutics's latest financial reports the company's current EPS (TTM) is S-$4.33. In 2025 the company made an earnings per share (EPS) of S-$4.93 an increase over its 2024 EPS that were of S-$6.76.

EPS history for Intellia Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.33-12.27%
2025S-$4.93-27.05%
2024S-$6.76-2.96%
2023S-$6.97-12.46%
2022S-$7.9664.36%
2021S-$4.8456.67%
2020S-$3.09
2018S-$2.566.99%
2017S-$2.4071.4%
2016S-$1.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
S-$1.74-59.82%๐Ÿ‡บ๐Ÿ‡ธ USA